Skip to content
★ Sign in to follow
DT

Duska Therapeutics, Inc. Stock: price and insider trades · United States

No insider purchase over the last 90 days. The latest, by KUO JAMES S, was filed 04 Sept 2008.

Duska Therapeutics, Inc.: what insiders have been doing

This page follows insider dealings at Duska Therapeutics, Inc. as filed with SEC (Form 4). Nothing new has been filed by managers of Duska Therapeutics, Inc. in twelve months, the latest record being from 26 September 2008.

Our records for Duska Therapeutics, Inc. go back to 2006, with 9 purchases and 26 sales on the open market in total.

Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.

Insider Decl.
38
Thresholds
n/a
Buy Volume
€179,453
9 ops. · all time
Sell Volume
€57,736
26 ops. · all time

Financial data

· cache

Last declaration on 26 September 2008
Declarations38 total
  • ◆
    DirectorExecutives
    2,000 USD0SEC
    4,445 shares@ US$0.45Duska Common StockSEC:0001213900-08-001874:0
  • ◆
    DirectorExecutives
    4,642 USD0SEC
    10,315 shares@ US$0.45Duska Common StockSEC:0001213900-08-001872:0
  • ◆
    DirectorExecutives
    1,000 USD0SEC
    1,961 shares@ US$0.51Duska Common StockSEC:0001213900-08-001872:1
  • ▲
    Chief Executive OfficerExecutives
    310 USD0SEC
    1,000 shares@ US$0.31DUSKA Common StockSEC:0001213900-08-001728:0
    Canonical exit: 2 Dec 2008 (T+90)
  • ▲
    Chief Executive OfficerExecutives
    180 USD0SEC
    900 shares@ US$0.20DUSKA Common StockSEC:0001213900-08-001682:0
    Canonical exit: 23 Nov 2008 (T+90)
  • ▲
    Chief Executive OfficerExecutives
    600 USD0SEC
    2,000 shares@ US$0.30DUSKA Common StockSEC:0001213900-08-001686:0
    Canonical exit: 25 Nov 2008 (T+90)
  • ▲
    DirectorExecutives
    8,112 USD0SEC
    14,749 shares@ US$0.55Duska Common StockSEC:0001213900-08-000462:0
    Canonical exit: 2 Jun 2008 (T+90)
  • ▲
    DirectorExecutives
    2,119 USD0SEC
    3,853 shares@ US$0.55Duska Common StockSEC:0001213900-08-000464:0
    Canonical exit: 5 Jun 2008 (T+90)
  • ▲
    DirectorExecutives
    17,165 USD0SEC
    57,217 shares@ US$0.30Duska Common StockSEC:0001213900-08-000350:0
    Canonical exit: 9 Jul 2007 (T+90)
  • ▲
    Chief Executive OfficerExecutives
    550 USD0SEC
    1,000 shares@ US$0.55DUSKA Common StockSEC:0001144204-07-066531:0
    Canonical exit: 5 Mar 2008 (T+90)
  • ▲
    Related company / holdingExecutives
    100,000 USD0SEC
    5,000,000 shares@ US$0.02Common StockSEC:0001392316-07-000004:0
    Canonical exit: 7 Jun 2007 (T+90)
  • ▲
    10% OwnerExecutives
    108,338 USD0SEC
    5,416,921 shares@ US$0.02Common StockSEC:0001392316-07-000005:0
    Canonical exit: 7 Jun 2007 (T+90)
  • ▼
    10% OwnerExecutives
    563 USD0SEC
    12,500 shares@ US$0.045Common StockSEC:0001250853-07-000002:0
  • ▼
    10% OwnerExecutives
    4,500 USD0SEC
    50,000 shares@ US$0.09Common StockSEC:0001250853-06-000160:0
  • ▼
    10% OwnerExecutives
    704 USD0SEC
    6,400 shares@ US$0.11Common StockSEC:0001250853-06-000135:0
  • ▼
    10% OwnerExecutives
    1,000 USD0SEC
    10,000 shares@ US$0.10Common StockSEC:0001250853-06-000135:1
  • ▼
    10% OwnerExecutives
    770 USD0SEC
    7,000 shares@ US$0.11Common StockSEC:0001250853-06-000124:0
  • ▼
    10% OwnerExecutives
    792 USD0SEC
    7,200 shares@ US$0.11Common StockSEC:0001250853-06-000124:1
  • ▼
    10% OwnerExecutives
    900 USD0SEC
    10,000 shares@ US$0.09Common StockSEC:0001250853-06-000123:0
  • ▼
    10% OwnerExecutives
    1,600 USD0SEC
    10,000 shares@ US$0.16Common StockSEC:0001250853-06-000114:0
  • ▼
    10% OwnerExecutives
    800 USD0SEC
    5,000 shares@ US$0.16Common StockSEC:0001250853-06-000109:0
  • ▼
    10% OwnerExecutives
    2,250 USD0SEC
    15,000 shares@ US$0.15Common StockSEC:0001250853-06-000109:1
  • ▼
    10% OwnerExecutives
    4,800 USD0SEC
    30,000 shares@ US$0.16Common StockSEC:0001250853-06-000109:2
  • ▼
    10% OwnerExecutives
    2,600 USD0SEC
    10,000 shares@ US$0.26Common StockSEC:0001250853-06-000104:0
  • ▼
    10% OwnerExecutives
    5,250 USD0SEC
    25,000 shares@ US$0.21Common StockSEC:0001250853-06-000104:1

25 of 38 declarations

About Duska Therapeutics, Inc.

Duska Therapeutics, Inc. is a company focused on developing innovative therapies. It aims to provide solutions for serious and unmet medical needs.